Congratulations to Chris Vazquez and Rishav Chatterjee on passing their doctoral preliminary examinations.

Chris is developing a series of histone deacetylase 10 (HDAC10) inhibitors, and new tetrazolone scaffolds for HDAC11 inhibitors. Rishav’s research focuses on HDAC6 inhibitors and the total synthesis of himalensine A.

This milestone reflects their scientific progress and sustained effort. Congratulations, Chris and Rishav!